|
Resolution: standard / high Figure 3.
Comparison of 0.5-year, 1-year PFS between non-CIK group and CIK group. OR, odds ratio; PFS, progression-free survival; non-CIK, non-CIK-based therapy;
CIK, CIK-based therapy. The fixed effects model (Mantel-Haenszel method) was used
in this analysis.
Ma et al. Experimental Hematology & Oncology 2012 1:11 doi:10.1186/2162-3619-1-11 |
